SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-17-005752
Filing Date
2017-08-04
Accepted
2017-08-04 17:00:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7584866_13g.htm SC 13G 114404
  Complete submission text file 0000919574-17-005752.txt   115973
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82467 | Film No.: 171009337
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G